The DOI matches its Crossref record; the references it cites are not checked yet.
Evaluation and treatment of hirsutism in premenopausal women: An endocrine society clinical practice guideline
Abstract
Objective: To update the "Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline," published by the Endocrine Society in 2008. Participants: The participants include an Endocrine Society-appointed task force of seven medical experts and a methodologist. Evidence: This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation system to describe the strength of recommendations and the quality of evidence. The task force commissioned two systematic reviews and used the best available evidence from other published systematic reviews and individual studies. Consensus Process: Group meetings, conference calls, and e-mail communications facilitated consensus development. Endocrine Society committees, members, and cosponsoring organizations reviewed and commented on preliminary drafts of the guidelines. Conclusion: Wesuggest testing for elevated androgen levels in allwomenwith an abnormal hirsutism score. We suggest against testing for elevated androgen levels in eumenorrheic women with unwanted local hair growth (i.e., in the absence of an abnormal hirsutism score). For most women with patient-important hirsutism despite cosmetic measures (shaving, plucking, waxing), we suggest starting with pharmacological therapy and adding direct hair removal methods (electrolysis, photoepilation) for those who desire additional cosmetic benefit. For women with mild hirsutism and no evidence of an endocrine disorder, we suggest either pharmacological therapy or direct hair removal methods. For pharmacological therapy, we suggest oral combined estrogen-progestin contraceptives for the majority of women, adding an antiandrogen after 6 months if the response is suboptimal. We recommend against antiandrogen monotherapy unless adequate contraception is used. We suggest against using insulin-lowering drugs. For most women who choose hair removal therapy, we suggest laser/photoepilation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the assessment could be biased by inaccurate measurement of SHBG [35].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [35]
In the citing paper
“Mass spectrometry after extraction and liquid or gas chromatography has the highest accuracy, but is expensive, is not routinely used, and standardized [35].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [35]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 183 · Cited by 339
Research works printed but not linked: 20
- Rios, 2013, Clinical assessment of body hair in Colombian women: determining the cutoff score that defines hirsutism, Biomedica, 33, 370
- Azziz, 2000, Idiopathic hirsutism, Endocr Rev, 21, 347
- American College of Obstetricians and Gynecologists, 2002, ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists: number 41, December 2002, Obstet Gynecol, 100, 1389
- Saeed, 1993, Treatment of hirsutism in polycystic ovarian syndrome with Diane, 50 mcg ethinyl estradiol and 2 mg cyproterone acetate, 109
- Al-Khawajah, 1998, Finasteride for hirsutism: a dose finding study, Saudi Med J, 19, 19
- Carmina, 1991, Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism, Obstet Gynecol, 78, 845
- Heiner, 1995, Comparison of a gonadotropin-releasing hormone agonist and a low dose oral contraceptive given alone or together in the treatment of hirsutism, J Clin Endocrinol Metab, 80, 3412
- Carr, 1995, Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study, J Clin Endocrinol Metab, 80, 1169
- Azziz, 1995, Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study, J Clin Endocrinol Metab, 80, 3406
- Carmina, 1994, Physiological estrogen replacement may enhance the effectiveness of the gonadotropin-releasing hormone agonist in the treatment of hirsutism, J Clin Endocrinol Metab, 78, 126
- Tiitinen, 1994, Estrogen replacement does not potentiate gonadotropin-releasing hormone agonist-induced androgen suppression in treatment of hirsutism, J Clin Endocrinol Metab, 79, 447
- Bouzari, 2005, The role of number of treatments in laser-assisted hair removal using a 755-nm alexandrite laser, J Drugs Dermatol, 4, 573
- Nilforoushzadeh, 2011, Comparison between sequentional treatment with diode and alexandrite lasers versus alexandrite laser alone in the treatment of hirsutism, J Drugs Dermatol, 10, 1255
- Eremia, 2001, Laser hair removal: long-term results with a 755 nm alexandrite laser, Dermatol Surg, 27, 920
- Vachiramon, 2012, Patient satisfaction and complications following laser hair removal in ethnic skin, J Drugs Dermatol, 11, 191
- Shapiro, 2001, Vaniqa--eflornithine 13.9% cream, Skin Therapy Lett, 6, 1
- Hennemann, 2001, [Eflornithine for hair removal. Topical application for hirsutism], Med Monatsschr Pharm, 24, 38
- Smith, 2006, Eflornithine cream combined with laser therapy in the management of unwanted facial hair growth in women: a randomized trial, Dermatol Surg, 32, 1237
- Rosenfeld, 1983, Androgenization in Women, 24
- Azziz, 1994, Clinical review 56: nonclassic adrenal hyperplasia: current concepts, J Clin Endocrinol Metab, 78, 810
Metadata
- Authors
- Martin, K. A., Anderson, R. R., Chang, R. J., Ehrmann, D. A., Lobo, R. A., Murad, M. H., Pugeat, M. M., & Rosenfield, R. L.
- Affiliations
- Massachusetts General Hospital (US)
- University of California San Diego (US)
- University of Chicago (US)
- Columbia University, New York, New York
- Mayo Clinic (US)
- Hospices Civils de Lyon (FR)
- Corresponding author
- Martin, Kathryn A
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2018-03-07
- Volume
- 103
- Issue
- 4
- Pages
- 1233-1257
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2885509473
- Cited by
- 339
- References
- 183
- Citations by year
- 2026: 44 · 2025: 34 · 2024: 43 · 2023: 51 · 2022: 46 · 2021: 47 · 2020: 43 · 2019: 19 · 2018: 11
- FWCI
- 32.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Keywords
- hirsutism, premenopausal women, hyperandrogenism, hirsutism treatment, polycystic ovary syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evaluation and treatment of hirsutism in premenopausal women: An endocrine society clinical practice guideline. https://app.cochat.ai/papers/10.1210/jc.2018-00241
- The paper
- Martin, K. A., Anderson, R. R., Chang, R. J., Ehrmann, D. A., Lobo, R. A., Murad, M. H., Pugeat, M. M., & Rosenfield, R. L. (2018). Evaluation and treatment of hirsutism in premenopausal women: An endocrine society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2018-00241
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.